2021-12-24
When the Christmas tree shines, when the bells jingle at the end of the year, the beauty and tenderness will come as promised.In this romantic winter day, the company prepared a warm Christmas-themed afternoon tea and staff birthday party.There are desserts, fruits, snacks, juices, drinks, full of Christmas rituals.Each oneof Bemei can draw a small Christmas gift prepared by the company, ...
More +2021-11-19
Shenzhen Beimei Pharmaceutical Co., Ltd. and MedPharm Ltd. (hereinafter referred to as "MedPharm") signed the Master Service Agreement (hereinafter referred to as the "Agreement") on 15th, Nov, 2021. According to the agreement, Beimei and MedPharm will cooperate in the development of a topical product for the treatment of immune diseases. MedPharm will be responsible for the preclinical research and development of products and technology transfer and will provide technical support for patent applications and product registrations. Beimei will have the exclusive right to commercialize the product in the global region, and will be responsible for the clinical study, registration, sales and promotion of the product and other commercialization activities.
2021-11-19
Shenzhen Beimei Pharmaceutical Co., Ltd. and MedPharm Ltd. (hereinafter referred to as "MedPharm") signed the Master Service Agreement (hereinafter referred to as the "Agreement") on 15th, Nov, 2021. According to the agreement, Beimei and MedPharm will cooperate in the development of a topical product for the treatment of immune diseases. MedPharm will be responsible for the preclinical research and development of products and technology transfer and will provide technical support for patent applications and product registrations. Beimei will have the exclusive right to commercialize the product in the global region, and will be responsible for the clinical study, registration, sales and promotion of the product and other commercialization activities.
2021-11-17
Generic name:Atomoxetine Hydrochloride Oral SolutionDosage form:Oral SolutionRegistration category: Class 4The first self-developed product of Beimei, Atomoxetine Hydrochloride Oral Solution, with its dossier completion of pharmacological studies and registration data, has been filed to the Center for Drug Evaluation (CDE) of the National Medical Products Administration o...
2021-11-17
Generic name:Atomoxetine Hydrochloride Oral SolutionDosage form:Oral SolutionRegistration category: Class 4The first self-developed product of Beimei, Atomoxetine Hydrochloride Oral Solution, with its dossier completion of pharmacological studies and registration data, has been filed to the Center for Drug Evaluation (CDE) of the National Medical Products Administration o...
2021-11-10
The launch conference of Beimei Pharmaceutical’s 奥维平®Oselavir®came to a successful conclusionIn this season of harvesting joy and happiness, the launch of 奥维平® , with generic name of Oseltamivir Phosphate for Oral Suspension,was held in Shenzhen with great expectation. Experts, scholars, cooperative suppliers, agents and investors from all over the world gathered together to w...
2021-11-10
The launch conference of Beimei Pharmaceutical’s 奥维平®Oselavir®came to a successful conclusionIn this season of harvesting joy and happiness, the launch of 奥维平® , with generic name of Oseltamivir Phosphate for Oral Suspension,was held in Shenzhen with great expectation. Experts, scholars, cooperative suppliers, agents and investors from all over the world gathered together to w...
2021-11-02
On November 2, 2021, Shenzhen Beimei Pharmaceutical Co., LTD. ("Beimei Pharmaceutical") and LTS Lohmann Therapie-Systeme AG ("LTS") signed a Feasibility Study Agreement ("the Agreement"). Under this Agreement, Beimei Pharmaceutical will cooperate with LTS in assessing the feasibility of the development of an oral thin film product for ...
2021-11-02
On November 2, 2021, Shenzhen Beimei Pharmaceutical Co., LTD. ("Beimei Pharmaceutical") and LTS Lohmann Therapie-Systeme AG ("LTS") signed a Feasibility Study Agreement ("the Agreement"). Under this Agreement, Beimei Pharmaceutical will cooperate with LTS in assessing the feasibility of the development of an oral thin film product for ...
2021-10-29
The Award Ceremony of 2021 Top 20 of Deloitte Shenzhen High-Tech High-Growth Groups and Rising Star Enterprises was successfully held On October 28 in 2021. Bemei Pharma was listed on the 2021 Shenzhen Rising Star Enterprises List.The Shenzhen Regional selection is co-sponsored by Deloitte China and Shenzhen Business Federation, aiming to discover and commend outstan...
2021-10-29
The Award Ceremony of 2021 Top 20 of Deloitte Shenzhen High-Tech High-Growth Groups and Rising Star Enterprises was successfully held On October 28 in 2021. Bemei Pharma was listed on the 2021 Shenzhen Rising Star Enterprises List.The Shenzhen Regional selection is co-sponsored by Deloitte China and Shenzhen Business Federation, aiming to discover and commend outstan...
2021-10-28
奥维平®，whose generic name is Oseltamivir Phosphate for Oral Suspension, was formally approved by NMPA, the National Medical Products Administration recently.Oseltamivir Phosphate for Oral Suspension, as the first product forcooperation between Shenzhen Bemei Pharma and HETERO LABS LIMITED of India, its Regulatory application was officially accepted by the C...
2021-10-28
奥维平®，whose generic name is Oseltamivir Phosphate for Oral Suspension, was formally approved by NMPA, the National Medical Products Administration recently.Oseltamivir Phosphate for Oral Suspension, as the first product forcooperation between Shenzhen Bemei Pharma and HETERO LABS LIMITED of India, its Regulatory application was officially accepted by the C...
2021-09-29
Drug review center held an expert seminar on hot issues of children's medicine research and developmentIn order to implement the important instructions of General Secretary Xi Jinping on children's medicine, carry out the practical activities of "I do practical things for the public", and make efforts to solve the shortage of children's medicine, the Center held an ex...
2021-09-29
Drug review center held an expert seminar on hot issues of children's medicine research and developmentIn order to implement the important instructions of General Secretary Xi Jinping on children's medicine, carry out the practical activities of "I do practical things for the public", and make efforts to solve the shortage of children's medicine, the Center held an ex...
2021-09-28
Announcement on Acceptance of Application for Posaconazole oral suspensionGeneric name:Posaconazole oral suspensionDosage form:oral suspension Registration category:5.2 categoryBeimeiPharmaandDeva Holding A.Ş. have come to an exclusive license agreement forPosaconazole oral suspensionin December 2020. According to the agreement,BeimeiPharmais responsible for the registration and...
2021-09-28
Announcement on Acceptance of Application for Posaconazole oral suspensionGeneric name:Posaconazole oral suspensionDosage form:oral suspension Registration category:5.2 categoryBeimeiPharmaandDeva Holding A.Ş. have come to an exclusive license agreement forPosaconazole oral suspensionin December 2020. According to the agreement,BeimeiPharmais responsible for the registration and...
2021-06-01
Always with Beimei, Always with love--Happy Children's DayGift for children on Children's Day by Center for Drug Evaluation, NMPATo further encourage research and development of children's drug, NMPA website open the "children's drug column" in the hot column on June 1, 2021, the children's drug-related policies and regulations, guidelines, train...
2021-06-01
Always with Beimei, Always with love--Happy Children's DayGift for children on Children's Day by Center for Drug Evaluation, NMPATo further encourage research and development of children's drug, NMPA website open the "children's drug column" in the hot column on June 1, 2021, the children's drug-related policies and regulations, guidelines, train...
